Header Logo

PRASUN JALAL

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6620 MAIN
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Surgery
    DivisionSurgery-Transplant Division


    Collapse Overview 
    Collapse overview
    Prasun K. Jalal, M.D is Stan and Sue Partee endowed chair in Hepatology, Assistant Professor of Surgery in the Division of Abdominal Transplantation of the Michael E. DeBakey Department of Surgery and in the Department of Medicine, Section of Gastroenterology and Hepatology, at Baylor College of Medicine. Dr. Jalal is board certified in gastroenterology, internal medicine and transplant hepatology. Dr. Jalal earned his medical degree from Postgraduate Institute of Medical Education and Research, Chandigarh, India. His extensive training includes training in gastroenterology and hepatology at St. James Hospital in Leeds, England. He completed a fellowship in gastroenterology at Long Island Jewish Medical Center-Albert Einstein College of Medicine, New York and in transplant hepatology at Mount Sinai School of Medicine, New York. Dr. Jalal's clinical interests include viral hepatitis, liver transplant, liver cancer and autoimmune hepatitis.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dunn W, Li Y, Singal AK, Simonetto DA, D?az LA, Idalsoaga F, Ayares G, Arnold J, Ayala-Valverde M, Perez D, Gomez J, Escarate R, Fuentes-L?pez E, Ramirez-Cadiz C, Morales-Arraez D, Zhang W, Qian S, Ahn JC, Buryska S, Mehta H, Dunn N, Waleed M, Stefanescu H, Bumbu A, Horhat A, Attar B, Agrawal R, Cabezas J, Echavar?a V, Cuy?s B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Higuera-de-la-Tijera F, Kulkarni AV, Rao PN, Guerra-Salazar P, Skladan? L, Kub?nek N, Prado V, Clemente-Sanchez A, Rincon D, Haider T, Chacko KR, Romero GA, Pollarsky FD, Restrepo JC, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Marciano S, Dirchwolf M, Vargas V, Jim?nez C, Hudson D, Garc?a-Tsao G, Ortiz G, Abraldes JG, Kamath PS, Arrese M, Shah VH, Bataller R, Arab JP. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study. Hepatology. 2024 Apr 12. PMID: 38607809.
      Citations:    
    2. Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK. Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. J Hepatocell Carcinoma. 2024; 11:595-606. PMID: 38525156; PMCID: PMC10961013.
      Citations:    
    3. Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Liu G, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI. Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America. Hepatology. 2024 Feb 20. PMID: 38381705.
      Citations:    Fields:    
    4. Al Lami Z, Kurtca M, Atique MU, Opekun AR, Siam MS, Jalal PK, Najafi B, Devaraj S, Mindikoglu AL. Dawn-to-dusk dry fasting decreases circulating inflammatory cytokines in subjects with increased body mass index. Metabol Open. 2024 Mar; 21:100274. PMID: 38455231; PMCID: PMC10918425.
      Citations:    
    5. Elsheikh M, El Sabagh A, Mohamed IB, Bhongade M, Hassan MM, Jalal PK. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management. World J Gastroenterol. 2023 Dec 14; 29(46):6028-6048. PMID: 38130738; PMCID: PMC10731159.
      Citations: 1     Fields:    Translation:Humans
    6. Gok Yavuz B, Datar S, Chamseddine S, Mohamed YI, LaPelusa M, Lee SS, Hu ZI, Koay EJ, Tran Cao HS, Jalal PK, Daniel-MacDougall C, Hassan M, Duda DG, Amin HM, Kaseb AO. The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma. Cancers (Basel). 2023 Oct 07; 15(19). PMID: 37835569; PMCID: PMC10571776.
      Citations:    
    7. Hatia RI, Eluri M, Hawk ET, Shalaby A, Karatas E, Shalaby A, Abdelhakeem A, Abdel-Wahab R, Chang P, Rashid A, Jalal PK, Amos CI, Han Y, Armaghany T, Shroff RT, Li D, Javle M, Hassan MM. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347. PMID: 37540502.
      Citations: 1     Fields:    Translation:Humans
    8. Toyoda H, Pi?ero F, Mendizabal M, Cheinquer H, Casadei-Gardini A, Weinmann A, Peck-Radosavljevic M, Dufour JF, Radu P, Sarin SK, Kumar M, Wang JH, Tangkijvanich P, Sukeepaisarnjaroen W, Uojima H, Nozaki A, Takaguchi K, Hiraoka A, Matsuura K, Watanabe T, Tsuji K, Ishikawa T, Itobayashi E, Kanneganti M, Melendez-Torres J, Parikh ND, Jalal PK, Ridruejo E, Shiha G, Soliman R, Atsukawa M, Abe H, Shimada N, Mikami S, Singal AG, Johnson PJ, Nakamuta M. Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2024 01; 22(1):72-80.e4. PMID: 37442316.
      Citations: 1     Fields:    Translation:HumansCells
    9. Abuelazm MT, Cheema HA, Jafar U, Awad AK, Atef M, Abdalshafy H, Alashwah M, Shahid A, Awan RU, Afifi AM, Jalal PK, Aziz H. Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec; 17(7):741-751. PMID: 37306478.
      Citations:    Fields:    
    10. Mohamed IB, Ismail MS, El Sabagh A, Afifi Abdelwahab AM, Polychronopoulou E, Kuo YF, Hassan M, Goss JA, Kanwal F, Jalal PK. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes. Cancer Med. 2023 07; 12(14):15011-15025. PMID: 37326440; PMCID: PMC10417193.
      Citations: 1     Fields:    Translation:Humans
    11. Sacleux SC, Khemichian S, Stein LL, Shetty K, Lindenmeyer CC, Simonetto DA, Rahimi RS, Jalal PK, Kriss MS, Im GY, Jou JH, Fortune BE, Cholankeril G, Kuo A, Mahmud N, Saliba F, Sundaram V, Jalan R, Multi-Organ Dysfunction and Evaluation for Liver Transplantation (MODEL) Consortium, Hernaez R, Karvellas CJ, Liu Y, Boike JR, Izzy M, Lin MV, Kanwal F, Artzner T. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727. PMID: 37315809.
      Citations:    Fields:    Translation:Humans
    12. D?az LA, Fuentes-L?pez E, Ayares G, Idalsoaga F, Arnold J, Valverde MA, Perez D, G?mez J, Escarate R, Villal?n A, Ram?rez CA, Hernandez-Tejero M, Zhang W, Qian S, Simonetto DA, Ahn JC, Buryska S, Dunn W, Mehta H, Agrawal R, Cabezas J, Garc?a-Carrera I, Cuy?s B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de-la-Tijera F, Kulkarni AV, Rao PN, Salazar PG, Skladan? L, Bystrianska N, Clemente-Sanchez A, Villaseca-G?mez C, Haider T, Chacko KR, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Marciano S, Dirchwolf M, Vargas V, Jim?nez C, Louvet A, Garc?a-Tsao G, Roblero JP, Abraldes JG, Shah VH, Kamath PS, Arrese M, Singal AK, Bataller R, Arab JP. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis. JHEP Rep. 2023 Aug; 5(8):100727. PMID: 37456675; PMCID: PMC10339256.
      Citations: 1     
    13. Singal AG, Ghaziani TT, Mehta N, Zhou K, Grinspan LT, Benhammou JN, Moon AM, Yang JD, Salgia R, Pillai A, Zheng E, Rich NE, Gopal P, Jalal P, Verna E, Yekkaluri S, Phen S, Melendez-Torres J, Alshuwaykh O, Choi H, Junus K, Grady J, Song M, Leven EA, Yum J, Gowda V, Alsudaney M, Hernandez P, Desai N, Parikh ND. Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3). PMID: 36881615; PMCID: PMC9995094.
      Citations: 1     Fields:    Translation:Humans
    14. Elgenidy A, Afifi AM, Jalal PK. Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018. Cancer Epidemiol Biomarkers Prev. 2022 Dec 05; 31(12):2169-2176. PMID: 36099432.
      Citations:    
    15. Cheema HA, Shafiee A, Athar MMT, Shahid A, Awan RU, Afifi AM, Shah J, Jalal PK. No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis. J Infect. 2023 02; 86(2):154-225. PMID: 36462586; PMCID: PMC9711899.
      Citations: 1     Fields:    Translation:HumansCells
    16. Mindikoglu AL, Park J, Opekun AR, Abdulsada MM, Wilhelm ZR, Jalal PK, Devaraj S, Jung SY. Dawn-to-dusk dry fasting induces anti-atherosclerotic, anti-inflammatory, and anti-tumorigenic proteome in peripheral blood mononuclear cells in subjects with metabolic syndrome. Metabol Open. 2022 Dec; 16:100214. PMID: 36506940; PMCID: PMC9731888.
      Citations: 1     
    17. Elgenidy A, Afifi AM, Jalal PK. Gallbladder Wall Thickness as a Non-Invasive Marker for Esophageal Varices: A Systematic Review and Meta-Analysis. J Clin Exp Hepatol. 2023 May-Jun; 13(3):509-517. PMID: 37250888; PMCID: PMC10213855.
      Citations:    
    18. Jalal PK. Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat? Cancer. 2022 10 01; 128(19):3441-3442. PMID: 35942799.
      Citations:    
    19. Lymberopoulos P, Prakash S, Shaikh A, Bhatnagar A, Allam AK, Goli K, Goss JA, Kanwal F, Rana A, Kowdley KV, Jalal P. Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 01 01; 29(1):15-25. PMID: 35770428; PMCID: PMC9800641.
      Citations:    Fields:    
    20. El Sabagh A, Mohamed IB, Aloor FZ, Abdelwahab A, Hassan MM, Jalal PK. Current Status of Biomarkers and Molecular Diagnostic Tools for Rejection in Liver Transplantation: Light at the End of the Tunnel? J Clin Exp Hepatol. 2023 Jan-Feb; 13(1):139-148. PMID: 36647415; PMCID: PMC9840072.
      Citations: 1     
    21. Shiha G, Soliman R, Mikhail NNH, Toyoda H, Uojima H, Nozaki A, Takaguchi K, Hiraoka A, Atsukawa M, Abe H, Matsuura K, Mikami S, Watanabe T, Tsuji K, Ishikawa T, Suri V, Osinusi A, Ni L, Zou J, Sarin SK, Kumar M, Jalal PK, Hashim MA, Hassan M, Mousa NH, Eslam M, Waked I, Carrat F, Azzi J, Nathalie GC, Lopez SA, Ba?ares R, Ahumada AM. International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients. J Viral Hepat. 2022 09; 29(9):807-816. PMID: 35657138.
      Citations:    Fields:    
    22. Afifi AM, Elgenidy A, Hashim M, Awad AK, Jalal PK. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Rev Med Virol. 2022 11; 32(6):e2353. PMID: 35441759.
      Citations:    Fields:    
    23. Keeling SS, McDonald MF, Anand A, Handing GE, Prather LL, Christmann CR, Jalal PK, Kanwal F, Cholankeril G, Goss JA, Rana A. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646. PMID: 35304775; PMCID: PMC9310351.
      Citations:    Fields:    Translation:Humans
    24. Elgenidy A, Afifi AM, Awad AK, Jalal PK. Utility of serum angiopoietin-2 as diagnostic marker of hepatocellular carcinoma: A systematic review and diagnostic test accuracy meta-analysis. Clin Res Hepatol Gastroenterol. 2022 05; 46(5):101909. PMID: 35318139.
      Citations:    Fields:    Translation:Humans
    25. Cholankeril G, Goli K, Rana A, Hernaez R, Podboy A, Jalal P, Da BL, Satapathy SK, Kim D, Ahmed A, Goss J, Kanwal F. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329. PMID: 34310738; PMCID: PMC8426752.
      Citations: 4     Fields:    Translation:HumansCells
    26. Moussa I, Day RS, Li R, Kaseb A, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med. 2021 10; 10(20):7308-7319. PMID: 34535983; PMCID: PMC8525131.
      Citations: 1     Fields:    Translation:Humans
    27. Zheng J, Daniel CR, Hatia RI, Stuff J, Abdelhakeem AA, Rashid A, Chun YS, Jalal PK, Kaseb AO, Li D, Hassan MM. Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA-Based Study. Hepatology. 2021 12; 74(6):3161-3173. PMID: 34233041; PMCID: PMC8639645.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    28. Ismail MS, Mohamed I, Polychronopoulou E, Goss JA, Kuo YF, Kanwal F, Jalal PK. Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021; 8:701-711. PMID: 34235107; PMCID: PMC8254565.
      Citations:    
    29. Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Parker R, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Kulkarni AV, Rao PN, Prado V, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Mendizabal M, Garrido ML, Bessone F, Marcelo JS, Piombino D, Kim W, Vargas V, Zamarripa F, Lucey MR, Verna E, Brown RS, Abraldes JG, Shah VH, Kamath PS, Singal AK, Bataller R, Arab JP, D?az LA, Baeza N, Idalsoaga F, Fuentes-L?pez E, Arnold J, Ram?rez CA, Cabezas J, Garc?a-Carrera I, Cuy?s B, Higuera-de la Tijera MF, Guerra Salazar P, Skladan? L, Bystrianska N, Clemente-Sanchez A, Rinc?n D, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Narvaez A, Dirchwolf M, Arancibia JP, Altamirano J, Araujo RC, Duarte-Rojo A, Rautou PE, Issoufaly T, Torre A, Mathurin P, Louvet A, Garc?a-Tsao G, Gonz?lez JA, Roblero JP, Arrese M. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 11; 75(5):1026-1033. PMID: 34166722.
      Citations: 1     Fields:    Translation:Humans
    30. Moussa I, Day RS, Li R, Du XL, Kaseb AO, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults. Nutrients. 2021 Jun 11; 13(6). PMID: 34208122; PMCID: PMC8230753.
      Citations: 5     Fields:    Translation:HumansAnimals
    31. Abdulsada MM, Wilhelm ZR, Opekun AR, Devaraj S, Jalal PK, Mindikoglu AL. The effect of four-week intermittent fasting from dawn to sunset on circulating brain-derived neurotrophic factor levels in subjects with metabolic syndrome and healthy subjects. Metabol Open. 2021 Mar; 9:100070. PMID: 33376976; PMCID: PMC7758552.
      Citations: 1     
    32. Mindikoglu AL, Abdulsada MM, Jain A, Jalal PK, Devaraj S, Wilhelm ZR, Opekun AR, Jung SY. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341. PMID: 33110154; PMCID: PMC7592042.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    33. Ismail MS, Hassan M, Khaderi SA, Yousry WA, Kamal El-Din MM, Bahaa El-Din MM, El Sayed OA, Kaseb AO, Goss JA, Kanwal F, Jalal PK. Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma. World J Hepatol. 2020 Sep 27; 12(9):628-640. PMID: 33033569; PMCID: PMC7522560.
      Citations: 1     
    34. Ismail MS, Hassan M, Martinez-Camacho A, May SB, Goss JA, Kanwal F, Jalal PK. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int. 2020 08; 33(8):925-935. PMID: 32314442.
      Citations: 1     Fields:    Translation:Humans
    35. Mindikoglu AL, Abdulsada MM, Jain A, Choi JM, Jalal PK, Devaraj S, Mezzari MP, Petrosino JF, Opekun AR, Jung SY. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteomics. 2020 04 15; 217:103645. PMID: 31927066; PMCID: PMC7429999.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    36. Satapathy SK, Jiang Y, Agbim U, Wu C, Bernstein DE, Teperman LW, Kedia SK, Aithal GP, Bhamidimarri KR, Duseja A, Maiwall R, Maliakkal B, Jalal P, Patel K, Puri P, Ravinuthala R, Wong VW, Abdelmalek MF, Ahmed A, Thuluvath PJ, Singal AK, Global NAFLD Consortium. Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. Liver Transpl. 2020 01; 26(1):68-79. PMID: 31665561.
      Citations: 5     Fields:    Translation:Humans
    37. Mindikoglu AL, Coarfa C, Opekun AR, Shah VH, Arab JP, Lazaridis KN, Putluri N, Ambati CR, Robertson MJ, Devaraj S, Jalal PK, Rana A, Goss JA, Dowling TC, Weir MR, Seliger SL, Raufman JP, Bernard DW, Vierling JM. Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Future Sci OA. 2019 Dec 17; 6(2):FSO441. PMID: 32025330; PMCID: PMC6997913.
      Citations:    
    38. Singal AG, Rich NE, Mehta N, Branch AD, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2. PMID: 31374215; PMCID: PMC6815711.
      Citations: 32     Fields:    Translation:Humans
    39. Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette CT, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983. PMID: 31357028; PMCID: PMC8174017.
      Citations: 7     Fields:    Translation:Humans
    40. Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1. PMID: 30660729; PMCID: PMC6598433.
      Citations: 43     Fields:    Translation:Humans
    41. Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47. PMID: 29291380; PMCID: PMC6037419.
      Citations: 11     Fields:    Translation:Humans
    42. Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799. PMID: 28579181; PMCID: PMC5901750.
      Citations: 33     Fields:    Translation:Humans
    43. Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia T, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst. 2014 May 09; 106(5). PMID: 24815863; PMCID: PMC4085880.
      Citations: 15     Fields:    Translation:Humans
    44. Reddy DN, Gupta R, Lakhtakia S, Jalal PK, Rao GV. Use of a novel transluminal balloon accessotome in transmural drainage of pancreatic pseudocyst (with video). Gastrointest Endosc. 2008 Aug; 68(2):362-5. PMID: 18534588.
      Citations: 3     Fields:    Translation:Humans
    45. Jalal PK, Bank S. Predicting severe acute pancreatitis: how have we done so far? J Gastroenterol Hepatol. 2007 Mar; 22(3):291-2. PMID: 17295756.
      Citations:    Fields:    Translation:Humans
    46. Orlent H, Selleslag D, Vandecasteele S, Jalal PK, Bank S, Hines J. Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement. Gastroenterology. 2007 Jan; 132(1):15-6, 467-8. PMID: 17241855.
      Citations: 1     Fields:    Translation:HumansAnimals
    47. Davidoff S, Jalal PK, Gao Z, Kops RJ, Robins T, Bank S. Gastric heterotopia in the rectum. Gastrointest Endosc. 2006 Jun; 63(7):1075-6; discussion 1076. PMID: 16733136.
      Citations: 1     Fields:    Translation:Humans
    JALAL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (148)
    Explore
    _
    Co-Authors (52)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _